Pramod K Srivastava

USPTO Granted Patents = 63 (Patent Applications = 6)

CIPO Patents = 2 (Patent Applications = 27)

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 1.3

ph-index = 29

Forward Citations = 1,677(Granted Patents)

Forward Citations (Not Self Cited) = 1,450(Dec 10, 2025)

Inventors with similar research interests:

Location History:

New York, NY (US) (2001)
Riverdale, NY (US) (1998 - 2009)
Avon, CT (US) (1999 - 2024)

Company Filing History:

University of Connecticut

patents

8 out of 242

Mount Sinai School of Medicine

patents

4. 2 out of 368

University of Notre Dame Du Lac

patents

where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...

Areas of Expertise:

Immunotherapy

Heat Shock Proteins

Neoepitopes

Cancer Treatment

Infectious Diseases

T Cell Generation

Peptide Complexes

Alpha(2) Macroglobulin

Stress Proteins

Vaccine Development

Tumor Rejection

Tissue Repair

63 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12311017 - Identification of immunologically protective neo-epitopes for the treatment of cancers (2025-05-27),

2. 11920202 - Unbiased identification of tumor rejection mediating neoepitopes (2024-03-05),

3. 11338026 - Identification of immunologically protective neo-epitopes for the treatment of cancers (2022-05-24),

4. 10501801 - Identification of tumor-protective epitopes for the treatment of cancers (2019-12-10),

5. 9566348 - Methods and compositions for the treatment of cancer and infectious disease using alpha(2) macroglobulin-antigenic molecule complexes (2017-02-14),

6. 9352019 - Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality (2016-05-31),

7. 9248172 - Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality (2016-02-02),

8. 8877204 - Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes (2014-11-04),

9. 8591890 - Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality (2013-11-26),

10. 8029808 - Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality (2011-10-04),

11. 7666581 - Methods for preparing compositions comprising heat shock proteins useful for the treatment of cancer and infectious disease (2010-02-23),

12. 7601359 - Compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress proteins (2009-10-13),

13. 7449557 - Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy (2008-11-11),

14. 7186515 - Alpha(2) macroglobulin receptor as a heat shock protein receptor and uses thereof (2007-03-06),

15. 7179462 - α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof (2007-02-20),

Title: The Innovative Journey of Inventor Pramod K Srivastava

Introduction: Pramod K Srivastava, a distinguished inventor hailing from Avon, CT (US), has made significant contributions to the field of innovations and patents with his groundbreaking work.

Latest Patents: Pramod K Srivastava holds several patents in the areas of biotechnology and medical research, showcasing his commitment to advancing scientific knowledge and technology.

Career Highlights: With a career spanning over two decades, Pramod K Srivastava has established himself as a leading figure in the world of inventions. His work has not only garnered recognition but has also paved the way for new developments in the industry.

Collaborations: Throughout his career, Pramod K Srivastava has collaborated with various research institutions, universities, and companies to bring his innovative ideas to life. His partnerships have been instrumental in the success of his projects.

Conclusion: In conclusion, Pramod K Srivastava's dedication to innovation and his remarkable contributions to the field of inventions have solidified his position as a respected inventor. His work continues to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.